About Tim Harkness
Tim Harkness is a director at Biolog.
Form D filings also name Tim Harkness as a director at LabVoice.
Tim Harkness reports to the SEC as a director or officer of 4 public companies, including Accelrys (ACCL), Symyx Technologies (SMMX) and Nektar Therapeutics (NKTR).
Tim Harkness first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Tim Harkness in the role, so the role may have started earlier or lasted longer.
LabVoice Inc.
Director
2022 · Carrboro, NC
LabVoice sells AI-guided workflow software to scientific laboratories.
AI
Accelrys, Inc.
Director
2010 – 2014 · Public company (ACCL)
SI
Symyx Technologies Inc.
Director
2008 – 2010 · Public company (SMMX)
NT
Nektar Therapeutics
SVP & Chief Financial Officer
2007 · Public company (NKTR)
MC
Molecular Devices Corp.
CFO/VP Finance
2006 – 2007 · Public company (MDCC)
Key Colleagues at Startups
The people Tim Harkness works with at each company, as listed on that company's latest Form D.
Biolog, Inc. · Form D, Feb 19, 2025
WS
William Snider
Director
RW
Robert Wicke
Chief Executive Officer and director
CS
Chad Souvignier
Director
AS
Anne Rogove Stone
Director
LabVoice Inc. · Form D, Oct 18, 2022
MP
Michael Piraino
Director
FB
Frederic Bost
Founder and director
MH
Mathew Hahn
Director
JH
Judy Ohm Hicks
Director